Diagnose von Willebrand disease using GPIbM technology

To correctly diagnose cases involving a bleeding anamnesis or a family history of von Willebrand disease and subsequently monitor patient response to therapy, physicians require a specific test for von Willebrand factor (VWF). A functional assay is the preferred screening method for detecting quantitative as well as qualitative defects of von Willebrand factor.¹ 

Now available for U.S. labs, the INNOVANCE® VWF Ac assay uses the guideline recommended VWF: GPIbM technology, allowing for a more accurate functional assessment of VWF with greater precision and heightened sensitivity. The GPIbM technology mimics true VWF function and detects variants missed by other assay technologies.